TSE:L

Loblaw Companies Ltd (L.TO)

66.14
+1.37 (2.12%)
as of Jun 24, 2026, 4:47:37 pm Market Open.
323 watching
0
Investor Insights
star iconJun 24, 2026, 12:00 am

This summary was created by AI, based on 15 opinions in the last 12 months.

Loblaw Companies Ltd. is Canada's leading food and drug retailer, effectively navigating challenges posed by inflation and competition. Analysts commend its strategic focus on discount formats like No Frills and the strong performance of its private labels, particularly the No Name brand. The acquisition of Shoppers Drug Mart has proven beneficial, generating robust free cash flow, and establishing a solid market position with organic growth prospects. While some experts express concerns about its current valuation being high, the company remains a reliable defensive choice in uncertain economic times. Overall, experts acknowledge its significant market share, operational efficiencies, and impressive revenue growth despite mixed sentiment regarding its valuation relative to competitors.

consensus icon
Consensus
Positive
valuation icon
Valuation
Overvalued
review icon
Similar
CST, CST
DON'T BUY
Has been a defensive play, so stock may not do much for awhile and until the earnings growth catches up to the P/E.
PAST TOP PICK
(Was a top pick on Dec 6 up 10%) Still likes.
DON'T BUY
Well run, but has a fairly high valuation.
BUY
Possibly at full value. A good bye for a long term hold.
DON'T BUY
Sold their holdings to buy Ahold. Too expensive.
DON'T BUY
A little expensive now. Good long term.
BUY
Good long tern but will stay flat for a while.
BUY
Good company.
BUY
Growth has continued, but stock price has stalled. A great opportunity.
BUY
Good dividend. A leader.
BUY
Still has decent growth. Good long term.
TOP PICK
Very good at retailing. Good management.
DON'T BUY
Defensive stock. Could have a drop when money leaves for growth stocks.
TOP PICK
Should continue to grow.
DON'T BUY
On the pricey side.
Showing 646 to 660 of 706 entries